Profound Medical PROF Interest And Accretion Expense
Interest And Accretion Expense at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept prof:InterestAndAccretionExpense.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's interest and accretion expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's interest and accretion expense?
- Profound Medical (PROF) reported interest and accretion expense of $5K in Q1 2026.
- How has Profound Medical's interest and accretion expense changed year-over-year?
- Profound Medical's interest and accretion expense decreased by 89.6% year-over-year, from $48K to $5K.
- What is the long-term trend for Profound Medical's interest and accretion expense?
- Over 2 years (2023 to 2025), Profound Medical's interest and accretion expense has grown at a -70.6% compound annual growth rate (CAGR), from $727K to $63K.
- What does interest and accretion expense mean?
- This represents the non-cash interest expense recognized through the accretion of debt discounts or the amortization of debt issuance costs. It reflects the periodic increase in the carrying value of financial liabilities without an immediate cash outlay. Monitoring this helps investors understand the true cost of capital and the impact of non-cash financing charges on earnings.